Accuracy of five self-report screening instruments for substance use in pregnancy

Addiction

Volumn 114, Issue 9, 2019, Pages 1683-1693

  Ondersma, Steven J ^a   Chang, Grace ^b   Blake Lamb, Tiffany ^c   Gilstad Hayden, Kathryn ^d   Orav, John ^e   Beatty, Jessica R ^a   Goyert, Gregory L ^f   Yonkers, Kimberly A ^d  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Alcohol; illicit drugs; opioids; pregnancy; risk identification; screening; substance use

Indexed keywords

ADULT; AFRICAN AMERICAN; CANNABIS USE; CAUCASIAN; CIGARETTE SMOKING; DRINKING BEHAVIOR; DRUG DEPENDENCE; FEMALE; HISPANIC; HUMAN; MASS SCREENING; OPIATE ADDICTION; PREGNANCY; PREGNANCY COMPLICATION; SELF REPORT; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE; UNITED STATES; YOUNG ADULT;

ADULT; AFRICAN AMERICANS; ALCOHOL DRINKING; CIGARETTE SMOKING; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; MARIJUANA USE; MASS SCREENING; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; SELF REPORT; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; UNITED STATES; YOUNG ADULT;

EID: 85067850200     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.14651     Document Type: Article

References (41)

1. Center for Behavioral Health Statistics and Quality National Survey on Drug Use and Health: Detailed Tables. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2016, p. 2017.
2. Lendoiro E., Gonzalez-Colmenero E., Concheiro-Guisan A., de Castro A., Cruz A., Lopez-Rivadulla M. et al. Maternal hair analysis for the detection of illicit drugs, medicines, and alcohol exposure during pregnancy. Ther Drug Monit 2013; 35: 296–304.
3. Bessa M. A., Mitsuhiro S. S., Chalem E., Barros M. M., Guinsburg R., Laranjeira R. Underreporting of use of cocaine and marijuana during the third trimester of gestation among pregnant adolescents. Addict Behav 2010; 35: 266–269.
4. Young-Wolff K. C., Tucker L. Y., Alexeeff S., Armstrong M. A., Conway A., Weisner C. et al. Trends in self-reported and biochemically tested marijuana use among pregnant females in California from 2009–2016. JAMA 2017; 318: 2490–2491.
5. Ondersma S. J., Svikis D. S., LeBreton J. M., Streiner D. L., Grekin E. R., Lam P. K. et al. Development and preliminary validation of an indirect screener for drug use in the perinatal period. Addiction 2012; 107: 2099–2106.
6. Donald K. A., Roos A., Fouche J. P., Koen N., Howells F. M., Woods R. P. et al. A study of the effects of prenatal alcohol exposure on white matter microstructural integrity at birth. Acta Neuropsychiatr 2015; 27: 197–205.
7. Khoury J. E., Milligan K., Girard T. A. Executive functioning in children and adolescents prenatally exposed to alcohol: a meta-analytic review. Neuropsychol Rev 2015; 25: 149–170.
8. El Marroun H., Schmidt M. N., Franken I. H., Jaddoe V. W., Hofman A., van der Lugt A. et al. Prenatal tobacco exposure and brain morphology: a prospective study in young children. Neuropsychopharmacology 2014; 39: 792–800.
9. Frank D. A., Kuranz S., Appugliese D., Cabral H., Chen C., Crooks D. et al. Problematic substance use in urban adolescents: role of intrauterine exposures to cocaine and marijuana and post-natal environment. Drug Alcohol Depend 2014; 142: 181–190.
10. Diaz S. D., Smith L. M., LaGasse L. L., Derauf C., Newman E., Shah R. et al. Effects of prenatal methamphetamine exposure on behavioral and cognitive findings at 7.5 years of age. J Pediatr 2014; 164: 1333–1338.
11. Bauer C. R., Shankaran S., Bada H. S., Lester B., Wright L. L., Krause-Steinrauf H. et al. The maternal lifestyle study: drug exposure during pregnancy and short-term maternal outcomes. Am J Obstet Gynecol 2002; 186: 487–495.
12. Sordo L., Indave B. I., Degenhardt L., Barrio G., Kaye S., Ruiz-Perez I. et al. A systematic review of evidence on the association between cocaine use and seizures. Drug Alcohol Depend 2013; 133: 795–804.
13. Pinto S. M., Dodd S., Walkinshaw S. A., Siney C., Kakkar P., Mousa H. A. Substance abuse during pregnancy: effect on pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol 2010; 150: 137–141.
14. Sarkar M., Einarson T., Koren G. Comparing the effectiveness of TWEAK and T-ACE in determining problem drinkers in pregnancy. Alcohol Alcohol 2010; 45: 356–360.
15. Bradley K. A., Boyd-Wickizer J., Powell S. H., Burman M. L. Alcohol screening questionnaires in women: a critical review. JAMA 1998; 280: 166–171.
16. Russell M., Martier S. S., Sokol R. J., Mudar P., Jacobson S., Jacobson J. Detecting risk drinking during pregnancy: a comparison of four screening questionnaires. Am J Public Health 1996; 86: 1435–1439.
17. Patrick S. W., Davis M. M., Lehmann C. U., Cooper W. O. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol 2015; 35: 650–655.
18. Grekin E. R., Svikis D. S., Lam P., Connors V., Lebreton J. M., Streiner D. L. et al. Drug use during pregnancy: validating the drug abuse screening test against physiological measures. Psychol Addict Behav 2010; 24: 719–723.
19. Beatty J. R., Chase S. K., Ondersma S. J. A randomized study of the effect of anonymity, quasi-anonymity, and certificates of confidentiality on postpartum women's disclosure of sensitive information. Drug Alcohol Depend 2014; 134: 280–284.
20. Yonkers K. A., Gotman N., Kershaw T., Forray A., Howell H. B., Rounsaville B. J. Screening for prenatal substance use: development of the substance use risk profile–pregnancy scale. Obstet Gynecol 2010; 116: 827–833.
21. Knight J. R., Shrier L. A., Bravender T. D., Farrell M., Vander Bilt J., Shaffer H. J. A new brief screen for adolescent substance abuse. Arch Pediatr Adolesc Med 1999; 153: 591–596.
22. Chang G., Orav E. J., Jones J. A., Buynitsky T., Gonzalez S., Wilkins-Haug L. Self-reported alcohol and drug use in pregnant young women: a pilot study of associated factors and identification. J Addict Med 2011; 5: 221–226.
23. Kennedy C., Finkelstein N., Hutchins E., Mahoney J. Improving screening for alcohol use during pregnancy: the Massachusetts ASAP program. Matern Child Health J 2004; 8: 137–147.
24. Watson E., Barnes H., Brown E., Kennedy C., Finkelstein N. Alcohol Screening Assessment in Pregnancy: the ASAP Curriculum. Cambridge, MA: Institute for Health and Recovery; 2003.
25. National Institute on Drug Abuse (NIDA). Resource Guide: Screening for Drug Use in General Medical Settings 2012 [National Institute on Drug Abuse website]. Available at: https://www.drugabuse.gov/publications/resource-guide-screening-drug-use-in-general-medical-settings/nida-quick-screen (accessed 24 March 2019) (Archived at http://www.webcitation.org/78Vt0b8bi on 20 May 2019).
26. Knight J. R., Sherritt L., Harris S. K., Gates E. C., Chang G. Validity of brief alcohol screening tests among adolescents: a comparison of the AUDIT, POSIT, CAGE, and CRAFFT. Alcohol Clin Exp Res 2003; 27: 67–73.
27. Knight J. R., Sherritt L., Shrier L. A., Harris S. K., Chang G. Validity of the CRAFFT substance abuse screening test among adolescent clinic patients. Arch Pediatr Adolesc Med 2002; 156: 607–614.
28. Chasnoff I. J., Wells A. M., McGourty R. F., Bailey L. K. Validation of the 4P's plus screen for substance use in pregnancy validation of the 4P's plus. J Perinatol 2007; 27: 744–748.
29. Chasnoff I. J., McGourty R. F., Bailey G. W., Hutchins E., Lightfoot S. O., Pawson L. L. et al. The 4P's plus screen for substance use in pregnancy: clinical application and outcomes. J Perinatol 2005; 25: 368–374.
30. Saitz R., Cheng D. M., Allensworth-Davies D., Winter M. R., Smith P. C. The ability of single screening questions for unhealthy alcohol and other drug use to identify substance dependence in primary care. J Stud Alcohol Drugs 2014; 75: 153–157.
31. Smith P. C., Schmidt S. M., Allensworth-Davies D., Saitz R. A single-question screening test for drug use in primary care. Arch Intern Med 2010; 170: 1155–1160.
32. Smith P. C., Schmidt S. M., Allensworth-Davies D., Saitz R. Primary care validation of a single-question alcohol screening test. J Gen Intern Med 2009; 24: 783–788.
33. Hoeke H., Roeder S., Bertsche T., Lehmann I., Borte M., von Bergen M. et al. Monitoring of drug intake during pregnancy by questionnaires and LC-MS/MS drug urine screening: evaluation of both monitoring methods. Drug Test Anal 2015; 7: 695–702.
34. Donovan D. M., Bigelow G. E., Brigham G. S., Carroll K. M., Cohen A. J., Gardin J. G. et al. Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction 2012; 107: 694–708.
35. Wolff K., Farrell M., Marsden J., Monteiro M. G., Ali R., Welch S. et al. A review of biological indicators of illicit drug use, practical considerations and clinical usefulness. Addiction 1999; 94: 1279–1298.
36. Fals-Stewart W., O'Farrell T. J., Freitas T. T., McFarlin S. K., Rutigliano P. The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol 2000; 68: 134–144.
37. Brown R. A., Burgess E. S., Sales S. D., Whiteley J. A., Evans D. M., Miller I. W. Reliability and validity of a smoking timeline follow-back interview. Psychol Addict Behav 1998; 12: 101–112.
38. Sobell L., Brown J., Leo G., Sobell M. The reliability of the alcohol timeline follow back when administered by telephone and by computer. Drug Alcohol Depend 1996; 42: 49–54.
39. Anderson B. L., Dang E. P., Floyd R. L., Sokol R., Mahoney J., Schulkin J. Knowledge, opinions, and practice patterns of obstetrician-gynecologists regarding their patients’ use of alcohol. J Addict Med 2010; 4: 114–121.
40. Vandevenne M., Vandenbussche H., Verstraete A. Detection time of drugs of abuse in urine. Acta Clin Belg 2000; 55: 323–333.
41. Substance Abuse and Mental Health Services Administration. Key Substance Use And Mental Health Indicators in the United States: Results from the 2016 National Survey on Drug Use and Health (HHS Publication no. SMA 17–5044, NSDUH Series H-52). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2017. Available at: http://datafiles.samhsa.gov/ (accessed 4 March 2019) (Archived at http://www.webcitation.org/78VvTLYix on 20 May 2019).